Multi-disciplinary treatment for cholangiocellular carcinoma

Area of Science:

• Oncology
• Gastroenterology
• Hepatology

Background:

• Cholangiocarcinoma (CC) comprises rare malignant tumors of the biliary tract, characterized by diagnostic difficulty and high mortality.
• CC is classified as intrahepatic (IH-CCC) or extrahepatic based on location.
• Intrahepatic cholangiocarcinoma (IH-CCC) is the second most frequent primary liver cancer, often presenting at advanced stages with unclear etiology.

Purpose of the Study:

• To review the current understanding of cholangiocarcinoma (CC), focusing on intrahepatic cholangiocarcinoma (IH-CCC).
• To discuss diagnostic modalities and treatment strategies for IH-CCC.
• To highlight the challenges in managing advanced and inoperable CC.

Main Methods:

• Review of existing literature on cholangiocarcinoma diagnosis and treatment.
• Analysis of imaging techniques such as MRI, CT, and PET in diagnosing IH-CCC.
• Evaluation of treatment outcomes for surgical resection, liver transplantation, chemotherapy, and radiation therapy.

Main Results:

• Imaging techniques like MRI, CT, and PET provide valuable diagnostic information for IH-CCC.
• Surgical resection is the only potentially curative treatment, contingent on patient selection and surgical expertise.
• Liver transplantation, combined with chemotherapy, offers long-term survival for select patients.
• Chemotherapy and radiation therapy are ineffective for inoperable patients, offering no survival benefit.

Conclusions:

• Intrahepatic cholangiocarcinoma (IH-CCC) presents significant diagnostic and therapeutic challenges.
• While surgery and transplantation offer hope for some, effective treatments for advanced or inoperable cases remain elusive.
• Further research is crucial to improve outcomes for cholangiocarcinoma patients.